United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 10,739 | 12,022 | 5,128 | 11,564 | 1,406 |
| Cost of Goods | 1,730 | 1,498 | 1,275 | 1,913 | 770 |
| Gross Profit | 9,009 | 10,524 | 3,853 | 9,651 | 636 |
| Operating Expenses | 13,171 | 14,134 | 10,665 | 11,943 | 8,381 |
| Operating Income | -3,432 | -3,112 | -6,537 | -1,379 | -6,975 |
| Interest Expense | 31 | 28 | 25 | 30 | 34 |
| Other Income | 439 | 535 | -5,626 | -1,771 | 1,331 |
| Pre-tax Income | -3,024 | -2,605 | -12,188 | -3,180 | -5,678 |
| Net Income Continuous | -3,024 | -2,605 | -12,188 | -3,180 | -5,678 |
| Net Income | $-3,024 | $-2,605 | $-12,188 | $-3,180 | $-5,678 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.29 | -0.08 | -0.14 |
| EPS Basic Continuous Ops | -0.07 | -0.06 | -0.29 | -0.08 | -0.14 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.29 | -0.08 | -0.14 |
| EPS Diluted Continuous Ops | -0.07 | -0.06 | -0.29 | -0.08 | -0.14 |
| EBITDA(a) | $-2,914 | $-2,622 | $-5,970 | $-325 | $-5,951 |